NEWTON, Mass., Sept. 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the following investor conferences in September: H.C. Wainwright 26th Annual Global Investment Conference Format: Podium presentation Date: Tuesday, September 10, 2024 Time: 9:00 a.m. ET Baird 2024 Global Healthcare Conference Format: Fireside chat Date: Wednesday, S ...